Kedbumin (albumin (human) 25%)
/ Kedrion
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 18, 2021
Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients
(clinicaltrials.gov)
- P4; N=3; Terminated; Sponsor: Kedrion S.p.A.; Phase classification: P2/3 ➔ P4
Clinical • Phase classification • Pediatrics
1 to 1
Of
1
Go to page
1